Evidence map›Paper›PMID 37243080›Full record

ArticleVaccines2023

A Case-Control Study on Factors of HPV Vaccination for Mother and Daughter in China.

Linyi Chen, Xihong Sun, Jing Luo, Yuanshan Zhang, Yu Ha, Xiaoxia Xu, Liandi Tao, Xuefeng Mu, Shengnan Gao, Yongchao Han and 14 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 1 country.

Linyi ChenDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.ORCID 0000-0002-7474-4075
Xihong SunJining Center for Disease Control and Prevention, Jining 272209, China.
Jing LuoSuzhou City Center for Disease Control and Prevention, Suzhou 234000, China.
Yuanshan ZhangLingcheng Center for Disease Control and Prevention, Dezhou 253500, China.
Yu HaDisease Control and Prevention Center of Jiuzhaigou County, Aba 623400, China.
Xiaoxia XuLongxi Center for Disease Control and Prevention, Dingxi 748000, China.
Liandi TaoChengguan Center for Disease Control and Prevention, Lanzhou 730020, China.
Xuefeng MuYilan Center for Disease Control and Prevention, Harbin 154800, China.
Shengnan GaoNangang Center for Disease Control and Prevention, Harbin 150006, China.
Yongchao HanQingfeng County Center for Disease Control and Prevention, Puyang 457000, China.
Chi WangNangang Center for Disease Control and Prevention, Harbin 150006, China.
Fuliang WangXiaoshan Center for Disease Control and Prevention, Hangzhou 311201, China.
Juan WangDisease Control and Prevention Center of Jiuzhaigou County, Aba 623400, China.
Bingying YangSi County Center for Disease Control and Prevention, Suzhou 234300, China.
Xiaoyan GuoQingfeng County Center for Disease Control and Prevention, Puyang 457000, China.
Yajie YuYilan Center for Disease Control and Prevention, Harbin 154800, China.
Xian MaChengguan Center for Disease Control and Prevention, Lanzhou 730020, China.
Lijian LiuJinxiang Center for Disease Control and Prevention, Jining 272200, China.
Wenmin MaJinxiang Center for Disease Control and Prevention, Jining 272200, China.
Pengmin XieLongxi Center for Disease Control and Prevention, Dingxi 748000, China.
Chao WangDepartment of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China.
Guoxing LiPuyang Center for Disease Control and Prevention, Puyang 457000, China.
Qingbin LuDepartment of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China.ORCID 0000-0002-2804-0827
Fuqiang CuiDepartment of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China.
Chinese Center For Disease Control and Prevention · CNPeking University · CNGansu Provincial Center for Disease Control and Prevention · CNXian Center for Disease Control and Prevention · CNHangzhou Center for Disease Control and Prevention · CN

Funding

China Postdoctoral Science Foundation 2022M720283
6 · The paper itself

Abstract

(1) Background: To explore the influencing factors of human papillomavirus (HPV) vaccination among mothers and daughters so as to provide evidence and strategies for improving the HPV vaccination rate of 9-18-years-old girls. (2) A questionnaire survey was conducted among the mothers of 9-18-year-old girls from June to August 2022. The participants were divided into the mother and daughter vaccinated group (M1D1), the mother-only vaccinated group (M1D0), and the unvaccinated group (M0D0). Univariate tests, the logistic regression model, and the Health Belief Model (HBM) were employed to explore the influencing factors. (3) Results: A total of 3004 valid questionnaires were collected. According to the regions, Totally 102, 204, and 408 mothers and daughters were selected from the M1D1, M1D0, and M0D0 groups, respectively. The mother having given her daughter sex education (OR = 3.64; 95%CI 1.70, 7.80), the mother's high perception of disease severity (OR = 1.79; 95%CI 1.02, 3.17), and the mother's high level of trust in formal information (OR = 2.18; 95%CI 1.26, 3.78) were all protective factors for both the mother and her daughter's vaccination. The mother's rural residence (OR = 0.51; 95%CI 0.28, 0.92) was a risk factor for vaccination of both mother and daughter. The mother's education of high school or above (OR = 2.12; 95%CI 1.06, 4.22), the mother's high level of HPV and HPV vaccine knowledge (OR = 1.72; 95%CI 1.14, 2.58), and the mother's high level of trust in formal information (OR = 1.72; 95%CI 1.15, 2.57) were protective factors of mother-only vaccination. The older the mother (OR = 0.95; 95%CI 0.91, 0.99) was classed as a risk factor for mother-only vaccination. "Waiting until the daughters are older to receive the 9-valent vaccine" is the main reason why the daughters of M1D0 and M0D0 are not vaccinated". (4) Chinese mothers had a high willingness to vaccinate their daughters with the HPV vaccine. The higher education level of the mother, giving sex education to the daughter, the older ages of mothers and daughters, the mother's high level of HPV and HPV vaccine knowledge, a high level of perception of the disease severity, and a high level of trust in formal information were promoting factors of HPV vaccination for mother and daughter, and rural residence was a risk factor to vaccination. To promote HPV vaccination in girls from 9-18 years old, communities could provide health education to rural mothers with low education levels; the government could advocate for HPV vaccination through issuing policy documents; and doctors and the CDC could popularize the optimal age for HPV vaccination to encourage mothers to vaccinate their daughters at the age of 9-14 years old.

Indexed as

health belief modelHPV vaccinevaccinationvaccination willingness

Identifiers

PMID37243080
PMCPMC10224422
OpenAlexW4376274575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.